Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Febuxostat in Gouty Obese Non-Diabetic Patients
NCT06995339Phase 2Completed
- Start
- May 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in gout. Started May 2025; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
gout
Beyond the preview
Go deeper on NCT06995339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06995339.